Results 171 to 180 of about 235,698 (344)

Delayed cardiac tamponade associated with prophylactic anticoagulation in patients undergoing coronary bypass grafting

open access: bronze, 1978
Mark S. Hochberg   +5 more
openalex   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai   +4 more
wiley   +1 more source

Left heart bypass without anticoagulation

open access: bronze, 1971
Richard M. Engelman   +4 more
openalex   +1 more source

Remote pulmonary artery pressure‐guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract Episodes of worsening heart failure (HF) are a major cause of unplanned hospitalizations. Their onset is usually preceded by an early increase in intracardiac pressures with subsequent worsening of symptoms due to congestion. Implantable devices allowing daily remote pulmonary artery pressure (PAP) monitoring are useful to identify early ...
Antoni Bayes‐Genis   +13 more
wiley   +1 more source

Safety of anticoagulation in the elderly: reasons for discontinuing therapy [PDF]

open access: bronze, 1992
Paddy O'Neill   +3 more
openalex   +1 more source

Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer

open access: yesEuropean Journal of Heart Failure, EarlyView.
Cardiac wasting‐associated cardiomyopathy in cancer patients. E/e', early diastolic filling velocity (E) over mitral annulus early diastolic tissue velocity (e'); GLS, global longitudinal strain; LV, left ventricular; LVEF, left ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion.
Markus S. Anker   +27 more
wiley   +1 more source

Prevention of venous thromboembolism after hip and knee replacement among older adults [PDF]

open access: yes, 2017
BACKGROUND: Venous thromboembolism (VTE) after total hip and knee replacement is a major patient safety threat, and pharmacologic prophylaxis is generally recommended. However, clinicians disagree on the optimal prophylaxis agent.
Ko, Darae
core  

Anticoagulants [PDF]

open access: yesNature Reviews Cardiology, 2018
openaire   +2 more sources

Home - About - Disclaimer - Privacy